Conclusion
Radiofrequency ablation of AVN is a highly effective method for
resistant atrial tachycardias that failed other management methods.
While plain catheters, EI, LPLD, and HPSD were equally safe and
effective, HPSD catheters had significantly shorter lesion time.
References
1. Huang SK, Bharati S, Graham AR, Lev M, Marcus FI, Odell RC. Closed
chest catheter desiccation of the atrioventricular junction using
radiofrequency energy—A new method of catheter ablation. Journal of
the American College of Cardiology. 1987;9(2):349-58.
2. Ruffy R, Imran MA, Santel DJ, Wharton JM. Radiofrequency Delivery
Through a Cooled Catheter Tip Allows the Creation of Larger
Endomyocardial Lesions in the Ovine Heart. Journal of Cardiovascular
Electrophysiology. 1995;6(12):1089-96.
3. Jaïs P, Shah DC, Haïssaguerre M, Hocini M, Garrigue S, Le Metayer P,
et al. Prospective Randomized Comparison of Irrigated-Tip Versus
Conventional-Tip Catheters for Ablation of Common Flutter. Circulation.
2000;101(7):772-6.
4. Ghia KK, Chugh A, Good E, Pelosi F, Jongnarangsin K, Bogun F, et al.
A nationwide survey on the prevalence of atrioesophageal fistula after
left atrial radiofrequency catheter ablation. Journal of Interventional
Cardiac Electrophysiology. 2009;24(1):33-6.
5. Garg L, Garg J, Gupta N, Shah N, Krishnamoorthy P, Palaniswamy C, et
al. Gastrointestinal complications associated with catheter ablation for
atrial fibrillation. International Journal of Cardiology.
2016;224:424-30.
6. Zucchelli G, Sirico G, Rebellato L, Marini M, Stabile G, Del Greco M,
et al. Contiguity Between Ablation Lesions and Strict Catheter Stability
Settings Assessed by
VISITAG<sup>TM</sup>
Module Improve Clinical Outcomes of Paroxysmal Atrial Fibrillation
Ablation ― Results From the VISITALY Study ―. Circulation Journal.
2018;82(4):974-82.
7. Wittkampf FHM, Nakagawa H. RF Catheter Ablation: Lessons on Lesions.
Pacing and Clinical Electrophysiology. 2006;29(11):1285-97.
8. Marijon E, Fazaa S, Narayanan K, Guy-Moyat B, Bouzeman A, Providencia
R, et al. Real-Time Contact Force Sensing for Pulmonary Vein Isolation
in the Setting of Paroxysmal Atrial Fibrillation: Procedural and 1-Year
Results: Real-Time Contact Force Sensing for Pulmonary Vein Isolation.
Journal of Cardiovascular Electrophysiology. 2014;25(2):130-7.
9. Bourier F, Duchateau J, Vlachos K, Lam A, Martin CA, Takigawa M, et
al. High‐power short‐duration versus standard radiofrequency ablation:
Insights on lesion metrics. Journal of Cardiovascular Electrophysiology.
2018;29(11):1570-5.
10. Frankel DS. Recipe for Ablation Success: Don’t Cook the Goose:
<b>Editorial Comment</b>.
Journal of Cardiovascular Electrophysiology. 2016;27(9):1045-6.
11. Bahnson TD. Strategies to Minimize the Risk of Esophageal Injury
durings Catheter Ablation for Atrial Fibrillation. Pacing and Clinical
Electrophysiology. 2009;32(2):248-60.
12. Barkagan M, Contreras‐Valdes FM, Leshem E, Buxton AE, Nakagawa H,
Anter E. High‐power and short‐duration ablation for pulmonary vein
isolation: Safety, efficacy, and long‐term durability. Journal of
Cardiovascular Electrophysiology. 2018;29(9):1287-96.
13. Hong KL, Borges J, Glover B. Catheter ablation for the management of
atrial fibrillation: current technical perspectives. Open heart.
2020;7(1):e001207.
14. .
16. Hoffmayer KS, Scheinman M. Current role of atrioventricular junction
(AVJ) ablation. Pacing Clin Electrophysiol. 2013;36(2):257-65.
17. Chatterjee NA, Upadhyay GA, Ellenbogen KA, McAlister FA, Choudhry
NK, Singh JP. Atrioventricular Nodal Ablation in Atrial Fibrillation.
Circulation: Arrhythmia and Electrophysiology. 2012;5(1):68-76.
18. Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, Mianulli
M, et al. The Ablate and Pace Trial: a prospective study of catheter
ablation of the AV conduction system and permanent pacemaker
implantation for treatment of atrial fibrillation. APT Investigators. J
Interv Card Electrophysiol. 1998;2(2):121-35.
19. Brignole M, Pokushalov E, Pentimalli F, Palmisano P, Chieffo E,
Occhetta E, et al. A randomized controlled trial of atrioventricular
junction ablation and cardiac resynchronization therapy in patients with
permanent atrial fibrillation and narrow QRS. Eur Heart J.
2018;39(45):3999-4008.
20. Parameswaran R, Al-Kaisey AM, Kalman JM. Catheter ablation for
atrial fibrillation: current indications and evolving technologies. Nat
Rev Cardiol. 2021;18(3):210-25.
21. Buist TJ, Zipes DP, Elvan A. Atrial fibrillation ablation strategies
and technologies: past, present, and future. Clin Res Cardiol.
2021;110(6):775-88.
22. Tomaiko E, Su WW. Comparing radiofrequency and cryoballoon
technology for the ablation of atrial fibrillation. Curr Opin Cardiol.
2019;34(1):1-5.
23. Ravi V, Poudyal A, Abid QU, Larsen T, Krishnan K, Sharma PS, et al.
High-power short duration vs. conventional radiofrequency ablation of
atrial fibrillation: a systematic review and meta-analysis. Europace.
2021;23(5):710-21.
24. Winkle RA. HPSD ablation for AF high-power short-duration RF
ablation for atrial fibrillation: A review. J Cardiovasc Electrophysiol.
2021;32(10):2813-23.
25. Chen CF, Wu J, Jin CL, Liu MJ, Xu YZ. Comparison of high-power
short-duration and low-power long-duration radiofrequency ablation for
treating atrial fibrillation: Systematic review and meta-analysis. Clin
Cardiol. 2020;43(12):1631-40.
26. Hlatky MA, Douglas PS, Cook NL, Wells B, Benjamin EJ, Dickersin K,
et al. Future directions for cardiovascular disease comparative
effectiveness research: report of a workshop sponsored by the National
Heart, Lung, and Blood Institute. Journal of the American College of
Cardiology. 2012;60(7):569-80.